Prior and concurrent administration of recombinant human megakaryocyte growth and development factor in patients receiving consolidation chemotherapy for de novo acute myeloid leukemia—a randomized, placebo-controlled, double-blind safety and efficacy study

✍ Scribed by K. Geissler; J.A. Liu Yin; A. Ganser; M.A. Sanz; J. Szer; A. Raghavachar; D. Hoelzer; C. Martinez; K. Taylor; L. Kanz; L.B. To; E. Archimbaud

• Publisher: Springer
• Year: 2003
• Tongue: English
• Weight: 218 KB
• Volume: 82
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-003-0737-7